- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Ricoh buys Lanier, voice line goes to Platinum
Ricoh and Lanier Worldwide have signed a definitive merger agreement, unanimously approved by Lanier's board, under which Ricoh will make a cash tender offer of $3 per share for all outstanding shares of Lanier common stock. However, Lanier's
Ricoh and Lanier Worldwide have signed a definitive merger agreement, unanimously approved by Lanier's board, under which Ricoh will make a cash tender offer of $3 per share for all outstanding shares of Lanier common stock. However, Lanier's voice products are not directly part of the deal. The merger with Ricoh is subject to regulatory approval and contingent on the sale of Lanier's voice business to Platinum Equity Holdings, a privately held firm specializing in acquiring and operating high-tech firms. The new voice products company, to be known as Lanier Health Care, has approximately 500 employees. Lanier should complete the transfer of its voice business within 30 days. Platinum projects sales in excess of $120 million for the 2001 fiscal year for Lanier Health Care.
© 2000 Miller Freeman Inc.
12/13/00, Issue # 118, page 3.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
